D
TerrAscend Corp. TSND.TO
TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

TerrAscend Corp. is a North American cannabis company operating primarily in the U.S. regulated cannabis industry, with activities spanning cultivation, processing, manufacturing, and retail distribution. The company is publicly listed in Canada under TSX (TSND) and operates as a multi-state operator serving adult-use and medical cannabis markets. TerrAscend’s business is vertically integrated, enabling control across the cannabis value chain from production to consumer-facing retail.

The company generates revenue through branded cannabis product sales and owned retail dispensaries, with a focus on limited-license, high-growth U.S. states. TerrAscend is positioned as a scaled operator with emphasis on premium branding, operational efficiency, and regulatory compliance. Founded in 2017, the company initially pursued a broader North American strategy, including Canada, but has since evolved to focus predominantly on U.S. state-level markets following regulatory and capital market developments.

Business Operations

TerrAscend operates through several core business segments, including Cultivation & Manufacturing, Wholesale Distribution, and Retail Cannabis Operations. The company produces flower, concentrates, vapes, and edible products under a portfolio of owned brands, and sells these products both through third-party dispensaries and its own retail network. Revenue is primarily generated from U.S. cannabis sales, with retail operations representing a significant and growing portion of total revenue.

Key operating assets include cultivation and processing facilities and a vertically integrated retail platform branded as The Apothecarium, alongside product brands such as Kind Tree. TerrAscend also owns Gage Cannabis, a Michigan-based cannabis operator acquired to strengthen its Midwest presence. Operations are conducted almost entirely in the United States; any remaining Canadian activity is limited to corporate, financing, or legacy holdings, with data inconclusive based on available public sources regarding material operating revenue from Canada.

Strategic Position & Investments

TerrAscend’s strategy centers on expanding scale and profitability in limited-license U.S. states through organic growth and targeted acquisitions. The company has invested heavily in retail expansion, brand development, and cultivation efficiency to improve margins and cash flow generation. Past acquisitions, including Gage Cannabis, were aimed at strengthening market share in strategic states and enhancing branded product distribution.

The company continues to invest in product innovation, including higher-margin derivatives and premium flower, while rationalizing non-core assets. TerrAscend’s strategic positioning emphasizes disciplined capital allocation, regulatory compliance, and readiness for potential U.S. federal cannabis reform. No material investments outside the cannabis sector have been verified based on available public sources.

Geographic Footprint

TerrAscend’s operations are concentrated in the United States, with active commercial presence in New Jersey, Pennsylvania, Michigan, California, and Maryland. These states represent some of the largest and most established cannabis markets in the country, offering both medical and adult-use sales opportunities. The company’s retail footprint is clustered in urban and high-income regions within these states.

Corporate headquarters functions are maintained in Canada, reflecting its public listing, while operational leadership and assets are U.S.-based. TerrAscend does not report material operations outside North America, and international investment activity beyond the U.S. and Canada has not been substantiated in public disclosures.

Leadership & Governance

TerrAscend was founded by Jason Wild, who continues to play a central role in the company’s strategic direction. The leadership team emphasizes operational discipline, regulatory credibility, and long-term value creation within a highly regulated industry. Governance is structured to align with Canadian public company standards while managing U.S. cannabis regulatory constraints.

Key executives include:

  • Jason Wild – Executive Chairman
  • David MacMillan – Chief Executive Officer
  • Keith Stauffer – Chief Financial Officer
  • Sam Scarpelli – Chief Compliance Officer
  • Tim Seymour – Director

The leadership team collectively brings experience in capital markets, regulated industries, and multi-state cannabis operations, guiding the company through market consolidation and regulatory complexity.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $180.25
B
AAPL NASDAQ $250.12
B
MSFT NASDAQ $395.55
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $126.52
B
Top Financial Stocks
See All »
B
B
JPM NYSE $283.44
B
V NYSE $307.14
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.08
Top Health Care Stocks
See All »
B
LLY NYSE $985.08
B
JNJ NYSE $241.52
B
AMGN NASDAQ $366.21
Top Real Estate Stocks
See All »
B
PLD NYSE $131.75